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Abstract 
Background: Pulmonary diseases are one of the most common causes of mortality worldwide. Lung transplantation 
is the only curative treatment in some cases. Very few lungs are available for transplantation and the 5-year survival 
after lung transplantation is 50%. Transplant recipients require immunosuppressant therapy in that’s time. 
Production of engineered lung tissue using stem cells is a promising approach. Extraction of natural ECM or 
decellularization of lung and application of it in tissue engineering is one of the most important strategies in this 
regard. It can preserve the natural characteristics of the ECM and would leads to the removal of the immunogen 
agents (MHC I, II) and allows reconstruction of graft.  
Objective: we have decellularized rat lung and cultured bone marrow stem cells on it to evaluate its differentiative 
potential. 
Methods: In this study along with extraction of rat lung, its femur and tibia bones were isolated for extraction of 
mesenchymal stem cells. Lung tissue was decellularized using SDS detergent. SEM and H&E staining used to assay 
decellularization. Mesenchymal stem cells were seed on the decellularized tissue sections and immunocytochemistry 
for CC10 and SPD performed on these cells after 21 days. 
Results: H&E slides of decellularized tissue did not show any cells. In electron microscope images of decellularized 
tissue alveolar structure was well maintained. Immunocytochemistry assay showed differentiation of seeded 
mesenchymal cells toward lung tissue cells. 
Conclusion: Decellularization take placed without any significant change in tissue structure. Decellularized tissue 
induced differentiation of bone marrow stem cells toward lung epithelial cells so natural ECM saved relatively. 
 








Pulmonary diseases are one the most common cause 
of mortality worldwide. Each year 7718 of Iranian 
and 400,000 of American people die due to lung 
disease. The incidence of lung diseases, especially 
COPD, has increased and it is expected to be the third 
leading cause of death in the world in 2020. For some 
lung diseases, including cystic fibrosis, emphysema, 
chronic obstructive pulmonary disease and idiopathic 
pulmonary fibrosis, lung transplantation is the only 
curative treatment (1, 2). 
 Unfortunately, very few lungs are available for 
transplantation and also the 5-year survival after lung 
transplantation is only 50%. Furthermore, transplant 
recipients require immunosuppressive therapy during 
that time. Therefore, new therapeutic strategies are 
needed. Now the promising and growing approach is 
production of engineered lung tissue in the laboratory 
that can be transplanted into patients. Engineered 
lung can be achieved by using of biological derived 
matrixes or synthetic scaffolds seeded with stem 
cells. In addition to lung, tissue engineering is used 
for regeneration of other tissues such as skin, blood 
vessels, cartilage, bone, trachea and more complex 
organs such as the heart and liver (3-9). Engineering 
of a whole organ was not possible yet and use of 
decellularized tissues and organs invented in tissue 
engineering. In this method cellular elements 
removes from tissue but intact important extracellular 
matrix (ECM) proteins and three-dimensional 
architecture of it leaves (1). Intact extracellular 
matrix of a tissue or organ can differentiate stem cells 
into its cells. Therefore, decellularized tissue can be 
used as a normal scaffold and a natural inducer in 
tissue engineering. Furthermore, the immune system 
is less stimulated by decellularized tissue thus the 
success rate of tissue engineered transplants in this 
way is high. 
There are several ways for decellularization including 
physical, enzymatic, and chemical methods. The 
chemical method is more efficient and common. In 
this method SDS, SDC and CHAPS are used (10-11). 
SDS is very effective to remove cellular components 
of the tissue, and compared to other detergents, SDS 
cause the complete elimination of nuclear debris and 
cytoplasmic proteins. It has been effective in 
decellularization of the host organs like kidney and 
liver. Usually, the duration of incubation with SDS is 
24 hours at concentrations between 0.1% -1% to 
reduce side effects of its use (12-16). 
In this study, we used 0.1% SDS in a new protocol 
for decellularization of rat lung and evaluated 
efficacy of this method and differentiative potential 
of decellulariezed lung tissue on bone marrow 
mesenchymal stem cells. 
 
Material and Methods 
Animals 
5 male rats from Iranian Razzi Institute housed in 
controlled environment (humidity and temperature) 
on a 12/12 hours light/dark cycle with free access to 
standard food and water. On the body weight 200-
250 gr animals used to isolation of mesenchymal 
stem cells and decellularization of lung. All efforts 
made to minimize animal suffering and to reduce the 
number of animals.  
 
Tissue harvest 
Tissue harvested by heart perfusion method. In this 
method PBS and other solutions perfused via heart 
into organ and whole body to remove blood. Animals 
sacrificed with ketamine and xylazine (100 mg/kg 
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and 10 mg/kg). A vertical section made in midthorax 
to access to heart. By use of a catheter from right 
ventricle perfusion started with 250cc PBS 
supplemented with Heparin 5000u/ml and 1% 
penicillin and streptomycin. After perfusion, lungs 
and femur bones harvested. Before harvesting trachea 
and main vein and artery of each lung identify and 
fixed with catheters to use in decellularization 
process. 
 
Decellularization of lung tissue 
The SDS 0.1% for 48 hours at 4 C was perfused from 
the trachea, veins and arteries with a handmade 
device while lung was flouted in the SDS 0.1%. Then 
0.1% Triton X100 in PBS similarly perfused in 72 
hours. Finally samples were perfused with PBS for 
24 h and keep in PBS at 4C prior to use. All 
procedures performed in a sterile condition. 
 
Hematoxillin and eosin staining 
Hematoxillin and eosin staining protocol (H & E) 
used to tissue assay. Lung tissue (before and after 
decellularization) fixed in paraformaldehyde 4%, 
after fixation transferred to tissue processor device to 
dehydration and clearing. Finally embedded in 
paraffin and sectioned in 5 micron diameter. Sections 
on glass lam stained with hematoxillin and eosin and 
observed in a light microscope. 
 
Morphology observation 
Morphology of decellularized lung ECM was assayed 
by a scanning electron microscope. Some sections 
with 2-5 mm thickness fixed in glutaraldehyde 2.5% 
and post fixed in osmium tetroxide 1% then 
dehydrated with alcohol and frieze dried for 4 hours. 
Finally sections observed with a scaning electron 
microscope.  
Isolation of bone marrow stem cells 
Bone marrow stem cells isolated from femurs of rats 
that their lungs used for decellularization. The femurs 
of animals removed by surgery and transferred into 
laminar flow hood. At a sterile condition two ends of 
each bones cut and bone marrow extracted by 
flashing of 5 ml DMEM from one end. Bone marrow 
cultured in DMEM supplemented with 10% FBS for 
24 hours. After 24 hours and then every 48 h the 
culture medium exchanged (17). The morphology of 
isolated cells examined under a phase-contrast 
microscope. The cells in third passage used to 
seeding in decellularized lung. 
 
Cell Seeding 
A suspension of bone marrow stem cells in DMEM 
(105 in 100µl) add to decellularized lung sections in 




21 days after cell seeding, immunohistochemistry 
done for CC10 and SPD proteins. Cultured BMSCs 
with decellularized lung sections fixed with 
paraformaldehyde 4% and washed 3 times with PBS. 
After permeablization for 30 min at room 
temperature with 0.25% Triton X-100 (Sigma), and 
blocking by applying 0.3% BSA (Sigma) with 5% 
NGS, sections were incubated for an overnight at 
48C with primary antibodies that were diluted in 
0.3% BSA/TBS. Then sections rinsed thrice with 
TBS prior to secondary antibody application. 
Secondary antibody was diluted 1:500 in 0.3% 
BSA/TBS and applied to cells for 3 hr at room 
temperature in the dark. Tissue was subsequently 
washed in TBS, and nuclei were counterstained with 
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lg/ml DAPI (Sigma-Aldrich) in TBS. The sections 




Use of perfusion method for tissue harvesting caused 
to remove of blood from tissue so tissue color after 
perfusion turned to white. 
 
 
Hematoxillin and eosin staining 
After decellularization by mentioned method, 
sections in 5 µm stained with H&E. In figure 1, panel 
A show normal long tissue and panel B show 
decellularized lung tissue. The nucleuses of the cells 
clearly see in the A but there is not any nucleus in B. 
After decellularization cytoplasm and nucleus 
destroyed and removed as showed in fig B. The result 
of H&E present decellularization was effective. 
 
 
Figure 1: H&E staining of lung tissue. A: Before decellularization, B: After decellularization. Cell nucleuses stained 
dark. 
Morphology assessment 
SEM can present three dimensional structure of a 
scaffold or tissue so we done it for normal and 
decellularized lung tissue. Our result showed in 
figure 2.There was no significant changes in 
microstructure of tissue after decellularization. 
Consequently our method of decellularization can 
save microstructure of normal tissue. 
Bone marrow stem cell isolation 
Bone marrow stem cells (BMSCs) attached in flask 
during 24h. Debris removed by medium exchanges. 
After tree passage they had a spindle shape. (Figure 
3) 
Immunohistochemistry 
BMSCs seeded in decellularized lung tissue assayed 
for differentiation and expression of CC10 and SPD 
markers 7, 14 and 21 days after seeding. Our result of 
Immunohistochemistry showed expression of these 
markers after 21days. Figure 4 showed this 
result.CC10 and SPD expressed in the BMSCs that 
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Figure 2: SEM graphs of lung tissue. A: Before decellularization, B: After decellularization 
 
 
Figure 3: Bone marrow mesenchymal stem cells in passage 3. 
 
Figure 4: Immunohistochemistry of cells seeded on decellularized lung tissue. A, B & C for CC10 and A’, B’ & C’ 
for SPD. Left column related to markers, middle column related to nucleus and right column is merged of them. 
 




Lung diseases are one of the leading causes of death 
in the world. In some cases lung transplantation is the 
only treatment. Lung transplantation such as other 
organ transplantation has its own limitations (1, 2). 
Therefore scientists are trying to engineer lung tissue. 
One promising technique in organ tissue engineering 
is use of decellularized organ in which intact 
important extracellular matrix (ECM) proteins and 
three-dimensional architecture of it leaves (1). Intact 
extracellular matrix of a tissue or organ can 
differentiate stem cells into its cells.    
Bone marrow mesenchymal stem cells can be easily 
obtain, store and survive for long time. More 
importantly, they can be used in autologous 
transplantation (18). The influence of normal cellular 
scaffolds prepared from the decellularized lung on 
the differentiation of MSC cells has not been studied. 
Thus the purpose of this study was to evaluate the 
effect of extracellular matrix scaffold considering its 
spatial form and key proteins on the differentiation of 
human mesenchymal stem cells. The lung cell 
scaffolds were prepared by two methods: sectional 
and whole organ decellularization. The MSC of bone 
marrow cells were seeded on scaffolds. The results 
showed that the ECM obtained from decellularized 
lung tissue can cause the differentiation of MSCs into 
cells expressing the CC10 and SPD, the markers of 
Clara epithelial cells and type II lung pneumocytes, 
respectively. This ECM obtained by SDS 
decellularization protocol. SDS, SDC and CHAPS 
were used in several studies (19).  
Detergents such as SDS led to the dissolution of the 
nuclear membrane and cell cytoplasm. It also desire 
to denature proteins by disrupting interactions 
between them. It also has a detrimental effect on 
glycosoaminoglycans (GAG) in the extracellular 
matrix, which reduces the mechanical stability of the 
scaffold (20, 21). Furthermore, SDS is very effective 
to remove cellular components of the tissue, and 
compared to other detergents, SDS cause the 
complete elimination of nuclear debris and 
cytoplasmic proteins (22). The SDS has been 
effective in decellularization of the host organs like 
kidney and liver (23). Usually, the duration of 
incubation with SDS is 24 hours at concentrations 
between 0.1% -1% (24, 25). 
In a comparative studies between chemical detergents 
commonly used in decellularization, including (SDS, 
SDC, CHAPS), CHAPS has been introduced as a 
mild detergent with minimal tissue damage and better 
collagen and elastin protection and tensile strength of 
the scaffold. However, this detergent is effective only 
in the elimination of nuclear proteins and compared 
with SDS it lacks the ability of removing cytoplasmic 
proteins (26, 27). 
In this study, we used 0.1% SDS, due to its high 
efficiency in the removal of cells and cell debris. It is 
the easiest and most accessible material for 
decellularization. This study showed that SDS as a 
strong detergent in tissue decellularization has the 
ability to maintain tissue proteins that provide 
cellular connectivity.  This result is consistent with 
other studies comparing the effects of detergents on 
decellularization of tissue. The SDS is weaker than 
other detergents in maintaining the protein structure. 
To check the result of decellularized context, the 
following tests are used: 
1. The tissue photos before and after decellularization 
to show the preserved macroscopic properties (28). 
2. Injecting (perfusing) a dye such as trypan blue 
after decellularization, to demonstrate the absence of 
any obstructions or restrictions on reagent or cell 
release after decellularization (29). 
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3. H & E slides preparation from normal and 
decellularized tissues to show effective removal of 
cells and to show healthy scaffolding (29). 
4. SEM images of the tissue before and after 
decellularization, to study the micro-structure of the 
alveoli (29). 
5. DAPI staining which is a fluorescent dye to check 
the presence of DNA after decellularization (23). 
6. Different types of tissue staining such as 
MassonsTrichomePicrosirius; gomoritrichrom (to 
assess collagen) and Pentachrom (to assess collagen 
and elastin); Alcian Blue (to assess 
glycosaminoglycans). 
The important point in decellularization is 
maintaining the structure of cell scaffolds and key 
proteins of cell matrix such as collagen, elastin and 
fibronectin. Our results of decellularization using H 
& E slides and electron microscopy SEM images 
showed that no cells were observed in H & E slides 
and the cell scaffold was maintained. Electron 
microscopy images showed that the structure of the 
alveoli and airways and blood vessels are intact and 
the overall texture is preserved. Also, comparing the 
normal and decellularized lung showed that the 
macroscopic structure of the tissue is preserved 
during the process. Our strong point compared with 
other studies is in using a strong detergent with high 
efficiency in the removal of cells and cellular debris 
than other detergents but with more tissue damage, 
the ability to manage it in order to minimize tissue 
damage using different concentrations of SDS and 
the decellularization times. 
The use of cell therapy using stem cells in a clinical 
setting is facing with obstructions such as concerns 
due to the lack of knowledge of the fate of 
transplanted stem cells in the damaged lung, and the 
regulation mechanisms of activation of resident 
progenitor cells in the lungs. However, information 
obtained from the experimental research on the safety 
of stem cell therapies in the treatment of chronic lung 
disease, showed promising results (30).The unique 
feature of mesenchymal stem cells compared to other 
stem cells, makes them the main candidates for 
therapeutic applications in lung disease. MSC can be 
useful in lung bioengineering strategies. They have 
several desirable features including support, 
adjustment and repair of the texture (30). 
For example, sheep MSCs showed promoting the 
growth of epithelial cells in co-cultures, 
transplantations and provisional matrix synthesis on 
the decellularized lung scaffolds which causes 
improved lung tissue in sheep model of emphysema. 
Similarly, the mouse MSCs in the elastase-induced 
damage model (32). 
In a study of type II alveolar cell co-cultured with 
lung MSCs it causes the expression of CK18, CK19, 
and SPC in the MSCs, showing the in vitro ability of 
stromal cells in the lung to differentiate into alveolar 
cells (33). In a study the differentiation ability of 
bone marrow mesenchymal cells into the type ІІ 
alveolar epithelial cells through BMSC co-culture 
with MRC-5 cells in SAGM modified media was 
shown (34). 
In another study the differentiation of lung stem cells 
into lung epithelial cells using growth factors such as 
HGF and FGF in the decellularized lung scaffold was 
designed with the help of a bioreactor (35). Another 
study uses the growth medium containing growth 
factor (FGF1) and (FGF7), epidermal growth factor, 
hepatocyte growth factor and insulin, for MSC 
differentiation into type II alveolar epithelial cells 
(36). 
According to the studies mentioned and the success 
of mesenchymal stem cells to differentiate into lung 
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tissue, in the study of mesenchymal stem cells 
derived from femur and tibia were used to 
differentiate into lung epithelial cells. But unlike the 
mentioned studies for the differentiation of these cells 
into the lung stem cells, the growth factors or co-
cultures were not used, but the difference is only 
performed by adjacent the stem cells with ECM. This 
distinction will facilitate the progress towards 
achieving the goal of engineered tissue in the 
treatment of lung disease. The markers of CC10 
(Clara cell secretory protein in the cytosolic and 
alveolar) and SPD (the secreted surfactant in type ІІ 
alveolar epithelial cells) was used to study the 
differentiation of the cells of the lung.  In other 
studies on the differentiation of stem cells into lung 
epithelial cells, the Clara cell secretory protein 
(CC10) and lung secreted surfactants (SPC, SPD) has 
been used (23,29). In this study, MSC extracted from 
rat bone marrow was seeded on the cellular scaffolds 
prepared from lung tissue. We found that some of the 
cells express CC10 and some cells express SPD. 
Differentiation markers were examined by 
immunocytochemistry test. 
In this study in order to investigate the effect of lung 
proteins on MSC differentiation, regardless of the 
effect of the cell scaffold, the supernatant of 
decellularized and homogenized tissue was also used 
in the process of mesenchymal cells culture, which 
showed a weak expression of CC10 and SPD 
markers. Therefore it can be concluded that the 
scaffold spatial shape will play an important part in 
the process differentiation. 
The MSCs seeded on the decellularized tissue of the 
whole organ results in cell death after 24 hours; 
which may be due to the complexity of the whole 
lung tissue in detoxification and removal of SDS 
debris after decellularization. This study showed that 
the microscopic structure of the extracellular matrix 
of decellularized lung has been well maintained and 
this matrix can act as a cell substrate, not only to 
survive seeded cells but also to provide 
differentiation potential of stem cells to the lungs. 
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